960. Deputy Ken O'Flynn asked the Minister for Health further to PQ No. 1241, to confirm whether the HSE holds a central or aggregate record of deaths of patients occurring during or following treatment funded under the treatment abroad scheme, in each of the past five years; and if she will make a statement on the matter. [73908/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Departmental Schemes.
299 questions match, newest first.
961. Deputy Ken O'Flynn asked the Minister for Health whether referring consultants are under an obligation to report complications, re-admissions or deaths following treatment funded under the treatment abroad scheme to the HSE or another body; if so, the basis of that obligation and the body to which such reports are made; and if she will make a statement on the matter. [73910/26]
962. Deputy Ken O'Flynn asked the Minister for Health if she will direct the HSE to establish a national record of clinical outcomes for patients treated under the treatment abroad scheme, given that the HSE has stated that patient outcomes, adverse incidents and patient safety fall outside the scheme's remit; and if she will make a statement on the matter. [73913/26]
1005. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1238, the name, grade and unit of the official within the Department of Health, as distinct from the HSE, who holds responsibility for monitoring the clinical outcomes of treatment funded under the treatment abroad scheme; if no official in the Department holds that responsibility, to state so directly; and if she will make a…
1017. Deputy Pádraig Rice asked the Minister for Health if the free HRT scheme will be extended to cover hormone replacement therapy for patients with congenital or permanent endocrine conditions, including testosterone replacement for Klinefelter syndrome. [74471/26]
724. Deputy Seán Kyne asked the Minister for Health whether the free HRT scheme will be extended to cover hormone replacement therapy for patients with congenital or permanent endocrine conditions, including testosterone replacement for Klinefelter syndrome. [70683/26]
868. Deputy Robert Troy asked the Minister for Health if she will ensure a cross border reimbursement application (details supplied) is processed without further delay. [68934/26]
616. Deputy Marie Sherlock asked the Minister for Health when the review of the mother and infant care scheme commenced; and when it is due for completion. [66809/26]
369. Deputy Pádraig Rice asked the Minister for Health if consideration is being given to the inclusion of an emergency treatment for severe allergic reactions under the drugs payment scheme (details supplied). [66170/26]
1234. Deputy Ken O'Flynn asked the Minister for Health further to PQ 42510/26, whether any official within her Department, as distinct from the HSE, holds responsibility for determining whether procedures funded under the treatment abroad scheme should be subject to national clinical audit or outcome monitoring; and if she will make a statement on the matter. [64755/26]
1235. Deputy Ken O'Flynn asked the Minister for Health the mechanism by which the HSE verifies that an overseas provider is a public healthcare service, as distinct from a private provider, prior to authorisation under the treatment abroad scheme; whether that verification is conducted centrally or relies on the referring consultant; and if she will make a statement on the matter. [64754/26]
1236. Deputy Ken O'Flynn asked the Minister for Health the number and total value of invoices under the treatment abroad scheme in each of the past three years where the final invoice exceeded the pre-authorisation estimate by 25% or more; the number of those cases in which payment was queried, reduced or withheld; and if she will make a statement on the matter. [64753/26]
1238. Deputy Ken O'Flynn asked the Minister for Health the name, grade and unit of the official within her Department, and separately within the HSE, who holds responsibility for clinical, as distinct from financial, outcome monitoring of procedures funded under the treatment abroad scheme; and if she will make a statement on the matter. [64752/26]
1241. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any record of clinical outcomes, including complications, readmissions or mortality, for patients treated under the treatment abroad scheme; if so, to provide those data in tabular form for each of the past five years; and if she will make a statement on the matter. [64751/26]
1242. Deputy Ken O'Flynn asked the Minister for Health the number of referrals under the treatment abroad scheme in each of the past five years that have been suspended, restricted, reviewed or escalated on grounds of clinical outcome, standard of care or patient safety, as distinct from cost or eligibility; and if she will make a statement on the matter. [64750/26]
537. Deputy Mattie McGrath asked the Minister for Health further to Parliamentary Question No. 942 of 16 June 2026, to provide the number of claims for reimbursement via the primary care reimbursement scheme for a patient’s first visit for purpose of termination of pregnancy during 2025 and to date in 2026; the number of claims for combined termination procedure and aftercare during 2025 and to date in 2026; and if s…
814. Deputy Jennifer Whitmore asked the Minister for Health the list of approved centres under the endometriosis surgery abroad interim scheme, by county; the centres in which women are required to cover the upfront cost of treatment; and if she will make a statement on the matter. [53151/26]
815. Deputy Jennifer Whitmore asked the Minister for Health the list of centres that are under review for inclusion in the endometriosis surgery abroad interim scheme, by county; when a decision is expected on each of those centres; and if she will make a statement on the matter. [53152/26]
819. Deputy Jennifer Whitmore asked the Minister for Health the number of applicants who have travelled abroad for endometriosis treatment under the endometriosis surgery abroad interim scheme since it was launched in 2025; and if she will make a statement on the matter. [53158/26]
820. Deputy Jennifer Whitmore asked the Minister for Health the number of applicants who have been approved to travel abroad for endometriosis treatment under the endometriosis surgery abroad interim scheme since it was launched in 2025; and if she will make a statement on the matter. [53159/26]
821. Deputy Jennifer Whitmore asked the Minister for Health the number of women who have engaged with the endometriosis surgery abroad interim scheme since it was launched in 2025; and if she will make a statement on the matter. [53160/26]
822. Deputy Jennifer Whitmore asked the Minister for Health the number of unsuccessful applicants there have been to the endometriosis surgery abroad interim scheme since it was launched in 2025; the reason those applicants were unsuccessful; and out of those unsuccessful applicants, the number that went on to receive endometriosis treatment through the Cross Border Directive; and if she will make a statement on the …
823. Deputy Jennifer Whitmore asked the Minister for Health the average wait time between applying to the endometriosis surgery abroad interim scheme and a decision being made on said application; and if she will make a statement on the matter. [53162/26]
824. Deputy Jennifer Whitmore asked the Minister for Health the average cost paid by patients being treated under the endometriosis surgery abroad interim scheme; the average wait time for reimbursement of upfront costs; and if she will make a statement on the matter. [53163/26]
825. Deputy Jennifer Whitmore asked the Minister for Health the average cost paid by patients being treated for endometriosis under the Cross Border Directive; the average wait time for reimbursement of upfront costs; and if she will make a statement on the matter. [53164/26]